Income Statement
CYCLERION THERAPEUTICS, INC.
CYCN
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY |
|---|---|---|---|---|---|---|---|
|
Revenue
|
2.07 | 2.00 | 0.30 | 1.63 | 3.94 | 2.30 | 4.51 |
|
Cost of Revenue
|
- | - | - | - | - | - | - |
|
Gross Profit
|
2.07 | 2.00 | 0.30 | 1.63 | 3.94 | 2.30 | 4.51 |
|
Operating Expenses
|
7.05 | 5.63 | 12.95 | 46.00 | 59.14 | 83.56 | 129.54 |
|
Research & Development
|
0.96 | 0.29 | 1.52 | 31.49 | 37.64 | 56.41 | 95.14 |
|
Selling, General & Administrative
|
6.09 | 5.34 | 8.13 | 14.50 | 20.62 | 28.82 | 34.40 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - |
|
Operating Income
|
-4.97 | -3.63 | -12.65 | -44.37 | -55.20 | -81.26 | -125.04 |
|
Non-Operating Income
|
1.45 | 0.57 | 0.36 | 0.29 | -0.02 | - | - |
|
Interest Income
|
- | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | 0.10 | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - |
|
Income Before Tax
|
-3.53 | -3.06 | -5.26 | -44.08 | -51.65 | -77.80 | -122.41 |
|
Income Tax Expense
|
- | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - |
|
Net Income
|
-3.53 | -3.06 | -5.26 | -44.08 | -51.65 | -77.80 | -123.01 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY |
|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - |
|
EBITDA
|
-4.97 | -3.63 | -12.65 | -44.27 | -54.70 | -78.96 | -122.34 |
|
Earnings Per Share (Basic)
|
-1.11 | -1.21 | -2.25 | -1.01 | - | - | - |
|
Diluted EPS
|
-1.11 | -1.21 | -2.25 | -1.01 | - | - | - |
|
Weighted Average Shares
|
3.18 | 2.52 | 2.34 | 43.47 | - | - | - |
|
Diluted Weighted Avg Shares
|
3.18 | 2.52 | 2.34 | 43.47 | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - |